Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: A new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus

Journal of Steroid Biochemistry and Molecular Biology

Volumn 68, Issue 1-2, 1999, Pages 41-50

  Geck, Peter ^a   Szelei, Jozsef ^a   Jimenez, Jesus ^a   Sonnenschein, Carlos ^a   Soto, Ana M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; LNCaP cells; Proliferation arrest; Subtractive library

Indexed keywords

ARTICLE; CANCER CELL; CELL PROLIFERATION; CHROMOSOME 13Q; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; PROSTATE CANCER;

AMINO ACID SEQUENCE; ANDROGENS; ANIMALS; BASE SEQUENCE; BRCA2 PROTEIN; CELL DIVISION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DNA, COMPLEMENTARY; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RATS; REPETITIVE SEQUENCES, AMINO ACID; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033035339     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00165-4     Document Type: Article

References (34)

1. Isaacs J.T. Antagonistic effect of androgen on prostatic cell death. Prostate. 5:1985;545-557.
2. Bruchovsky N., Lesser B., Van Doorn E., Craven S. Hormonal effects on cell proliferation in rat prostate. Vit. & Horm. 33:1975;61-102.
3. Sonnenschein C., Olea N., Pasanen M.E., Soto A.M. Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res. 49:1989;3474-3481.
4. Hayward S.W., Rosen M.A, Cunha G.R. Stromal-epithelial interactions in the normal and neoplastic prostate. Br. J. Urol. Suppl. 2:1997;18-26.
5. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., Mirand E.A., Murphy G.P. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1983;1809-1818.
6. Soto A.M., Lin T.M., Sakabe K., Olea N., Damassa D.A., Sonnenschein C. Variants of the human prostate LNCaP cell line as a tool to study discrete components of the androgen-mediated proliferative response. Oncology Res. 7:1995;545-558.
7. Kim I.Y., Kim J.H., Zelner D.J., Ahn H.J., Sensibar J.A., Lee C. Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line LNCaP. Endocrinology. 137:1996;991-999.
8. Kim I.Y., Ahn H.J., Zelner D.J., Shaw J.W., Sensibar J.S., Kim J.H., Kato M., Lee C. Genetic change in transforming growth factor-β receptor type I correlates with insensitivity to transforming growth factor-β1 in human prostate cancer cells. Proc. Am Assoc. Cancer Res. 37:1996;124.
9. Szelei J., Jimenez J., Soto A.M., Luizzi M.F., Sonnenschein C. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology. 138:1997;1406-1412.
10. Wang Z., Brown D.D. A gene expression screen. Proc. Natl. Acad. Sci. USA. 88:1991;11505-11509.
11. Geck P., Szelei J., Lin T- M, Sonnenschein C., Soto A.M. Expression of novel genes linked to the androgen induced proliferative shutoff in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 63:1997;211-218.
12. Soto A.M., Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 23:1991;87-94.
13. Chomczinsky P., Sacchi N. Single step method of RNA isolation by acid guanidinium-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:1991;19867-19870.
15. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115:1991;887-903.
16. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
17. Chen C.-Y., Shyu A.-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:1995;465-470.
18. Lupas A. Coiled-coils: new structures and new functions. Trends Biochem. Sci. 22:1996;375-382.
19. Beavil A.J., Edmeades R.L., Gould H.J., Sutton B.J. α-helical coiled-coil stalks in the low affinity receptor for IgE (FceRII/CD23) and related C-type lectins. Proc. Natl. Acad. Sci. USA. 89:1992;753-757.
20. Hanks S.K., Quinn A.M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Meth. Enzymol. 200:1991;38-62.
21. Taylor S.S., Knighton D.R., Zheng J., Ten Eyck L.F., Sowadsky J.M. Structural framework for the protein kinase family. Annu. Rev. Cell Biol. 8:1992;429-462.
22. Zhou Z.-X., Sar M., Simental J.A., Lane M.V., Wilson E.M. A ligand dependent bipartite nuclear targeting signal in the human androgen receptor. J. Biol. Chem. 269:1994;13115-13123.
23. Bouvier D., Baldacci G. The N-terminus of fission yeast DNA polymerase α contains a basic pentapeptide that acts in vivo as a nuclear localization signal. Mol. Biol. Cell. 6:1995;1697-1705.
24. Shapiro M.B., Senapathy P. RNA splice junctions in different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucl. Acids Res. 15:1987;7155-7174.
25. Couch F.J., Rommens J.M., Neuhausen S.L., Belanger C., Dumont M., Abel K., Bell R., Berry S. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics. 36:1997;86-99.
26. Olea N., Sakabe K., Soto A.M., Sonnenschein C. The proliferative effect of 'anti-androgens' on the androgen-sensitive human prostate tumor cell line LNCaP. Endocrinology. 126:1990;1457-1463.
27. Thiessen E.U. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer. 34:1974;1102-1107.
28. Tulinius H., Egilsson V., Olafsdottir G., Sigvaldason H. Risk of prostate ovarian and endometrial cancer among relatives of women with breast cancer. Br. Med. J. 305:1992;855-857.
29. Gudmundsson J., Johannesdottir G., Bergthorsson J.T., Arason A., Ingvarsson S., Egilsson V., Barkardottir R.B. Different tumor types from BRCA2 carriers show wild type chromosome deletions on 13q12-q13. Cancer Res. 55:1995;4830-4832.
30. Van den Berg J., Johansson O., Hakansson S., Olsson H., Borg A. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br. J. Cancer. 74:1996;1615-1619.
31. Cleton-Jansen A.-M., Collins N., Lakhani S.R., Weissenbach J., Devilee J.P., Cornelisse C.J., Stratton M.R. Loss of heterozygosity in sporadic breast tumors at the BRCA2 locus on chromosome 13q12-q13. Br. J. Cancer. 72:1995;1241-1244.
32. Garcia-Marco J.A., Caldas C., Price C.M., Wiedemann L.M., Ashworth A., Catovsky D. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood. 88:1996;1568-1575.
33. Caldas C., McGregor A., Wiedemann L., Catovsky D., Ashworth A., Garcia-Marco J. Evidence for the existence of a new tumor suppressor gene near the BRCA2 locus. Proc. Am. Assoc. Cancer Res. 38:1997;191.
34. Denison S.H., Kafer E., May G.S. Mutation in the bimD gene of Aspergillus nidulans confers a conditional mitotic block and sensitivity to DNA damaging agents. Genetics. 134:1992;1085-1096.